Phase II Study of Ofatumumab in Elderly Patients With Chronic Lymphocytic Leukemia (CLL)
Status:
Active, not recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if ofatumumab can help to control CLL.
The safety of this drug will also be studied.
Ofatumumab is designed to bind to the surface of the leukemia cells . This may cause the
leukemia cells to die.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborators:
GlaxoSmithKline National Comprehensive Cancer Network